改进了reovirus突变的瘤学活性,由于细胞附着减少,显示了增强的病毒传播
Francisca Cristi1,2,3, Maiah Walters1, Nashae Narayan1
1Department of Medical Microbiology and Immunology, University of Alberta, Edmonton AB T6G 2E1, Canada.
Molecular therapy oncolytics
|November 30, 2023
概括
被命名为超级病毒5 (SV5) 的转基因转基因reovirus显示出对乳腺癌的增强性抗瘤效应. 这种改进的癌症治疗依赖于病毒传播的增加,而不是更快的复制,为病毒瘤学提供了新的途径.
科学领域:
- 瘤学病毒学 瘤学病毒学
- 癌症基因治疗的基因疗法
- 分子病毒学分子病毒学.
背景情况:
- 野生类型的reovirus血清型3Dearing (T3wt) 是一个有前途的,非致病性瘤性病毒,但需要提高癌症治疗的效力.
- T3wt自然适应肠道环境,需要进行基因修饰以改善瘤细胞的感染性.
研究的目的:
- 通过基因工程改造reovirus,以提高对癌细胞的抗瘤作用.
- 在临床前癌症模型中评估修改后的reovirus突变的疗效.
主要方法:
- 使用斑块大小作为癌细胞病毒适应性衡量的reovirus突变的创建和体外评估.
- 在HER2+小鼠乳腺癌模型中评估瘤治疗功效.
- 在培养细胞中对病毒复制和传播的分析.
主要成果:
- 超级病毒5 (SV5),一个具有五种瘤突变的突变,在乳腺癌细胞中表现出最大的斑块大小.
- 与野生类型的reovirus (T3wt) 和PBS相比,SV5在小鼠中显示出优异的瘤减少和生存率的增加.
- 与T3wt相比,SV5在瘤中的扩散增加,这归因于癌细胞附着的减少,尽管复制率相似.
结论:
- 对reovirus的基因改造可以显著提高其瘤解毒功效.
- 增加病毒的传播,而不是更快的复制,是改善瘤病毒疗效的关键机制.
- 工程化reovirus,如SV5,具有增强癌症治疗的潜力.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K


